Αναζήτηση αυτού του ιστολογίου

Παρασκευή 18 Δεκεμβρίου 2020

Fwd: Severe Covid-19/A Boy with Seizure and Hypocalcemia

Severe Covid-19/A Boy with Seizure and Hypocalcemia



Resident Briefing
December 17, 2020
 
Teaching Topic
 
Featured Image

CLINICAL PRACTICE

Severe Covid-19

D.A. Berlin, R.M. Gulick, and F.J. Martinez

FREE CME Audio Comments

Patients with severe coronavirus disease 2019 (Covid-19) may become critically ill with acute respiratory distress syndrome, which typically begins approximately 1 week after the onset of symptoms.

 
Clinical Pearls
 
Who is most at risk for severe Covid-19?
Healthy persons of any age may become critically ill with Covid-19. However, age is the most important risk factor for death or critical illness, and the risk increases with each additional decade. People with chronic health conditions such as cardiovascular disease, diabetes mellitus, immunosuppression, and obesity are more likely to become critically ill from Covid-19. Severe disease is more common among men than among women. The risk is also increased among certain racial and ethnic groups such Black and Hispanic persons in the United States.
Does dexamethasone have a role in the treatment of patients with severe Covid-19?
A large, randomized clinical trial involving more than 6400 hospitalized patients with Covid-19 showed that dexamethasone significantly reduced 30-day mortality (17% reduction); benefit was limited to patients who required oxygen supplementation and appeared greater in patients receiving mechanical ventilation. Consequently, dexamethasone (or potentially other glucocorticoids) is now considered the standard of care for patients with severe Covid-19.
 
Morning Report Questions
 
Has remdesivir been shown to reduce mortality in patients with severe Covid-19?
Data from a randomized, placebo-controlled trial involving more than 1000 patients with severe Covid-19 showed that the antiviral agent remdesivir reduced time to clinical recovery; the benefit appeared greatest in patients who were receiving supplemental oxygen but were not intubated. The 29-day mortality in that trial was 11.4% with remdesivir and 15.2% with placebo (hazard ratio for death, 0.73; 95% confidence interval, 0.52 to 1.03). These data support the Food and Drug Administration (FDA) approval of remdesivir for the treatment of hospitalized patients with Covid-19 in October 2020. Recent preliminary results of a large, multinational, open-label, randomized trial did not show a reduction in in-hospital mortality with use of remdesivir. The combination of dexamethasone and remdesivir is increasingly used clinically, but its benefit has not been shown in randomized clinical trials.
What are some of the areas of uncertainty regarding the management of severe Covid-19?
It is unclear whether Covid-19 is associated with a distinct form of acute respiratory distress syndrome (ARDS) that would benefit from a new strategy of mechanical ventilation. However, most autopsies performed on patients with severe Covid-19 reveal the presence of diffuse alveolar damage, which is the hallmark of ARDS. If there are no contraindications, patients should receive standard thromboprophylaxis (e.g., subcutaneous low-molecular-weight heparin). Some case series of patients with severe Covid-19 have shown clinically significant thrombosis despite the use of thromboprophylaxis. However, the benefits and risks of the routine use of more intense prophylactic anticoagulation in patients are unknown. Having awake patients turn to the prone position while they breathe high concentrations of supplemental oxygen may improve oxygenation in patients with severe Covid-19. This approach is supported by data from prospective cohorts describing its use in nonintubated patients with severe hypoxemia. However, whether prone positioning can prevent intubation in patients with severe Covid-19 is unclear.
 
Teaching Topic
 
Featured Image

CASE RECORDS OF THE MASSACHUSETTS GENERAL HOSPITAL

Case 39-2020: A 29-Month-Old Boy with Seizure and Hypocalcemia

Y.V. Virkud and Others

CME

Childhood causes of vitamin D deficiency include obesity, malabsorption, and low sun exposure, as well as decreased nutritional intake.

 
Clinical Pearls
 
Is nutritional rickets rare in high-income countries?
Nutritional rickets is often thought of as a historical relic — the discovery of vitamin D and the implementation of supplementation and food-fortification strategies in the early 20th century sharply decreased the prevalence of what had been a common disease, particularly in urban centers. However, the incidence of vitamin D deficiency appears to be rising in high-income countries, and the prevalence is persistently high in low- and middle-income countries.
What are some of the risk factors for nutritional rickets?
In a 2015 case-finding survey of Canadian pediatricians, risk factors for nutritional rickets included demographic characteristics (recent immigration), physiological features (skin melanin content, food allergies, feeding challenges associated with prematurity, developmental delay, and maternal vitamin D deficiency), and aspects of diet (lack of vitamin D supplementation and dietary restrictions) and behavior (lack of sun exposure).
 
Morning Report Questions
 
How is severe, asymptomatic hypocalcemia that is associated with vitamin D deficiency managed?
Patients who have profound hypocalcemia that is complicated by severe symptoms (seizure or tetany) receive intravenous calcium to rapidly restore normocalcemia. Unfortunately, there is limited evidence from randomized, controlled trials to guide subsequent repletion of vitamin D stores. In 2016, an international panel developed recommendations for the prevention and management of nutritional rickets. The panel recommended a daily dosing strategy to minimize the risk of hypercalcemia but also recognized that a single high dose may be more feasible in some circumstances and thus offered dosing recommendations for this strategy, as well. Vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol) have similar efficacy when given in daily doses; some evidence suggests that vitamin D3 has better efficacy than vitamin D2 when given in a single dose. In addition, adequate calcium intake, through dietary calcium or supplementation, is necessary to support bone remineralization. Adequate calcium provision is also necessary to prevent hungry bone syndrome, a condition in which there is paradoxical worsening of hypocalcemia after initiation of vitamin D therapy. This condition is thought to be due to rapid bone-mineral uptake by the demineralized skeleton, and management may require very high doses of calcium, as well as occasional therapeutic doses of calcitriol (1,25-dihydroxyvitamin D), the active form of vitamin D.
How quickly do the radiographic changes of nutritional rickets improve with adequate treatment?
The response to treatment can be monitored by obtaining blood levels of calcium, phosphate, 25-hydroxyvitamin D, parathyroid hormone, and alkaline phosphatase and the urinary calcium:creatinine ratio approximately 4 weeks after the initiation of treatment and at monthly intervals until resolution of laboratory abnormalities. In most children with nutritional rickets, laboratory values will typically normalize and radiographs will show substantial healing after 3 months of adequate treatment, although some patients may require continued treatment.
 
Quote of the Week
 
"In this small study involving older adults, adverse events associated with the mRNA-1273 vaccine were mainly mild or moderate. The 100-μg dose induced higher binding- and neutralizing-antibody titers than the 25-μg dose, which supports the use of the 100-μg dose in a phase 3 vaccine trial."
E.J. Anderson and Others
Original Article, "Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults"
FREE CME Video
 
Multimedia
 
Quick Take Preview Image

QUICK TAKE

Phase 1 Study of a SARS-CoV-2 mRNA Vaccine in Older Adults

A recent phase 1 trial indicated that the Moderna mRNA-1273 vaccine had an acceptable safety profile and was immunogenic in participants younger than 55 years of age. The immune response to Covid-19 vaccine candidates in older populations is of paramount importance, since serious illness and death have been associated with older age. New research findings are summarized in a short video.

Videos in Clinical Medicine Image

VIDEOS IN CLINICAL MEDICINE

Lumbar Puncture

Lumbar puncture is indicated for both diagnostic and therapeutic reasons. Knowledge of the contraindications, the pertinent anatomy, and the methods to minimize the risk of complications is necessary for the safe and efficient performance of lumbar puncture. This procedure video demonstrates how to perform a lumbar puncture.


NEJM CareerCenter
Physician Jobs December 17, 2020
ENT New Mexico
Exciting opportunity in the Four Corners
Exciting Opportunity for an ENT in the Four Corners. Piñon Hills Ear, Nose, Throat and Allergy Specialists in Farmington, New Mexico is recruiting a general ENT to join an existing practice as a valuable member of our team. You can look forward to: $454,000 one year salary guarantee with three-year contract; $70,000 Sign-on bonus and relocation; Employed position duration negotiable, partnership track available 1:4 call Profit sharing/401K; Quality work/life balance....
Cardiology Massachusetts
Seeking full-time non-invasive Cardiologist in Concord
Cardiology practice opportunity, 25 minutes from Boston, quality-of-life, Find out why so many top physicians are practicing at Emerson Hospital. At Emerson you will find desirable practice location, strong relationships with academic medical centers, superb quality-of-life, competitive financial packages, and more. Emerson Hospital is seeking a full-time, experienced non-invasive cardiologist to join our well-established team in beautiful Concord, Mass. Join a successful and cohesive group....
Looking for a new practice opportunity? View these jobs and other listings at NEJM CareerCenter.

Search now for both permanents and locum tenens job in many specialties.

NEJM Knowledge+ Question of the Week
Question of the Week
Which one of the following additional tests is most appropriate at this time for an asymptomatic 65-year-old white man who has mild elevations in serum aminotransferases, lipids, and fasting glucose; a normal level of alkaline phosphatase; no history of alcohol use disorder; and negative testing for hepatitis B and C viruses?
Button On Antimitochondrial antibodies
Button On Serum ceruloplasmin
Button On Antinuclear antibodies
Button On Serum ferritin and transferrin saturation
Button On Liver biopsy
Submit
SPECIAL OFFER
Subscribe to the New England Journal of Medicine
The New England Journal of Medicine delivers the most significant, most clinically relevant research in medicine. Advance your knowledge with the information you trust to stay informed and improve patient care. Your subscription includes 52 weeks of NEJM.org access, 50 FREE article views from the NEJM Archive (1812–1989), and free access to all NEJM Weekly CME activities (Choose from over 350). Subscribe today.

FOLLOW US

Facebook Twitter Instagram LinkedIn YouTube

This email was sent to alsfakia@gmail.com.

You can sign up here to get the Resident Briefing delivered to your inbox.

Unsubscribe from this alert or update your preferences at My Alerts.

To ensure that you always receive the Resident Briefing, add the email address resebulletin@nejm.org to your address book.

The New England Journal of Medicine
860 Winter Street
Waltham, MA 02451
USA

Copyright © 2020 Massachusetts Medical Society. All rights reserved.

NEJM Group

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.